chemotherapy of metastatic gastro-intestinal cancer.cancer of the digestive tract is the commonestcause of death from neoplastic disease in the unitedstates.  a large number of patients with these forms ofincurable cancer may be candidates for specific anti-tumordrug therapy.  the criteria employed for the selectionof patients for systemic or regional chemotherapyare reviewed and methods of treatment are outlined.systemic chemotherapy, using fluorinated pyrimidines,the antifol, methotrexate, and the alkylating agent, cytoxan,has been found to be of significant practical valuein 10 to 30% of the patients receiving these anticancerdrugs.  protracted hepatic artery infusion chemotherapyin patients with primary and secondary hepatic neoplasmsand tumors of the biliary system has resulted inobjective tumor response and associated clinical benefitin 60% of the patients treated.  length of survival hasbeen prolonged in patients with advanced metastatic livercancer from primary tumors of the colorectum.  it isconcluded that systemic and regional cancer chemotherapy,in selected cases, has contributed to the practicalmanagement of patients with incurable cancer of thegastrointestinal tract.